Comparative effectiveness of several adjuvant therapies for patients with hepatocellular carcinoma with high-risk factors for recurrence after hepatectomy: a systematic review and meta-analysis
Adjuvant therapy following hepatectomy decreases the risk of recurrence, and HCC patients with high risks of recurrence may benefit. TACE, TKI, RT and HAIC-FOLFOX are effective methods for reducing recurrence after HCC with high risks of recurrence. RT appears to be the most effective adjuvant regimen.
Authors
- Haizhao Yi
- Zejin Zhao
- Zhiyan Li
- Yue Xiao
- Jinlong Liu
Institutions
- Chengde Medical University (CN)
Publication Details
- Journal
- Frontiers in Medicine
- Published
- 2025-12-30
- DOI
- https://doi.org/10.3389/fmed.2025.1692417
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00